Statement: to qualify for the primary clinical trial, patients must be identified as having hormone receptor positive advanced breast cancer, and must have had previous chemotherapy treatment for this
Primary_evidence: Inclusion Criteria:   Confirmed hormone receptor positive advanced breast cancer, postmenopausal women Exclusion Criteria:   Previous treatment for advanced breast cancer (previous treatment for early breast cancer is allowed).